Dacocare (Dacomitinib) 45mg*30's | Generic EGFR Inhibitor | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

分享
Product description

Generic Information: Dacocare (Laos)

Dacocare is a Lao-manufactured generic of dacomitinib, produced by ElementoPharma Co., Ltd. It is supplied as 45 mg tablets in a 30-tablet pack, matching the standard daily starting dose. As a second-generation, irreversible EGFR inhibitor, Dacocare delivers the same active ingredient as the originator brand, aimed at patients who need EGFR-mutated lung cancer therapy at a lower, out-of-pocket-friendly price.

What Is Dacocare Used For?

Dacocare is used as first-line monotherapy for non-small cell lung cancer (NSCLC) with EGFR exon 19 deletion or exon 21 L858R substitution mutations. It is prescribed only after genetic testing confirms one of these sensitizing mutations. The oral, once-daily format makes it well suited to long-term home treatment.

How Does Dacocare (Dacomitinib) Work?

The dacomitinib in Dacocare binds irreversibly to EGFR and, unlike first-generation drugs, also to HER2 and HER4. This covalent, pan-HER blockade keeps the cancer-driving growth signals off for longer, which translates into more durable disease control. The mechanism is the same as the originator's, which is why a bioequivalent generic can be used as a cost-saving substitute.

Indications

Dacocare is indicated for adults with locally advanced or metastatic NSCLC whose tumors carry an EGFR exon 19 deletion or exon 21 L858R mutation. It is not for EGFR wild-type disease and is not indicated for small-cell lung cancer. Confirm the mutation status before starting therapy.

Dosage

Take 45 mg once daily, with or without food, at about the same time each day. If you miss a dose, do not make it up with an extra tablet — continue with the next scheduled dose. Dose reduction may be needed if diarrhea or skin toxicity occurs. Avoid proton-pump inhibitors; use a locally-acting antacid or an H2-receptor antagonist timed at least 6 hours before or 10 hours after the dose.

Side Effects

The most frequent side effects are diarrhea, rash, paronychia, stomatitis, reduced appetite, dry skin, weight loss, hair loss, cough, and pruritus. Early use of anti-diarrheal agents and good skin care can keep most of these manageable. Interstitial lung disease is rare but serious; any new breathing difficulty should be reported immediately and the medicine stopped permanently if ILD is confirmed.

Storage

Keep Dacocare below 30°C in a dry place, inside the original package, and away from children. No cold storage is required.

Why Choose the GLT?

For uninsured or under-insured patients, Lao generic dacomitinib such as Dacocare is a far more economical option than the originator brand, whose Western list price can be several times higher. GLT sources from established manufacturers and provides the documentation needed for international delivery, so patients can continue therapy without exhausting their budget.

How to Order

To order Dacocare through GLT, message us on WhatsApp at +86 15234153837 or write to [email protected]. Tell us the strength, quantity, and your country, and our team will confirm stock, sourcing origin, and delivery details. We serve hospitals, pharmacies, and individual patients alike.

FAQ

Is Dacocare a generic of Vizimpro? Yes, Dacocare is a Lao-manufactured generic of dacomitinib, the active ingredient in Vizimpro, produced by ElementoPharma. It offers the same medicine at a lower price.

What strength does Dacocare come in? This listing is the 45 mg strength in a 30-tablet box, which is the standard once-daily starting dose for adults.

Where can I buy generic dacomitinib? Generic dacomitinib can be sourced through international suppliers such as GLT. Always verify the supplier and request proper documentation before purchasing.

Related Oncology Products

SPINRAZA(诺西那生钠)12mg/5mL | 中国购买 | SMA 疗法 | GLT

渤健首创的反义寡核苷酸 SMA 疗法,已获 NMPA 批准并纳入中国国家医保——从 GLT 购买,价格仅为欧美的一小部分。

Palutini(巴瑞替尼)4mg | 仿制 JAK1/JAK2 抑制剂 | Trans Continental Life Science & Pharmaceuticals (TLPH) | GLT

由 Trans Continental Life Science & Pharmaceuticals (TLPH)(老挝)生产的仿制巴瑞替尼(JAK1/JAK2 抑制剂)——用于类风湿关节炎、特应性皮炎和斑秃,是 Olumiant 的平价替代品。

KeZeRui 科瑞泽(阿伐曲泊帕)20mg*10片 | 四川科伦(中国)| GLT

KeZeRui——四川科伦药业的国采阿伐曲泊帕,中国一体化原料药+片剂制造商。

Mounjaro KwikPen(替尔泊肽)10–60mg/2.4mL 多剂量注射笔 | 礼来(美国)| GLT

Mounjaro KwikPen——礼来单患者多剂量注射笔,六种美国规格(10–60mg/2.4mL,各 4 剂)用于 2 型糖尿病。

Avabopa(阿伐曲泊帕)20mg*30片 | 老挝东盟制药 TLPH | GLT

Avabopa——老挝东盟制药(TLPH)阿伐曲泊帕 20mg,老挝注册号 07 L 0990/23

Tirzema(替尔泊肽)2.5/5/7.5mg/0.5mL 单剂量注射笔 | Incepta(孟加拉国)| GLT

Tirzema——Incepta Pharmaceuticals 替尔泊肽单剂量注射笔,三种官方规格(2.5/5/7.5mg/0.5mL),用于 2 型糖尿病和体重管理。

奥氟格列隆/奥格列龙(LuciOrfor)0.8–17.2mg 片剂 | 老挝仿制药 口服 GLP-1 | GLT

卢修斯制药(老挝)有限公司出品奥氟格列隆(奥格列龙)仿制药,6 档剂量递增方案,用于体重管理

奥氟格列隆/奥格列龙(OriYo)0.8–17.2mg 片剂 | 孟加拉仿制药 口服 GLP-1 | GLT

孟加拉国民制药(National Drug Co.)仿制奥氟格列隆,6 剂量递增用于体重管理